Parkwood LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,202
| Closed | -$212K | – | 184 |
|
2023
Q4 | $212K | Buy |
+2,202
| New | +$212K | 0.03% | 115 |
|
2023
Q2 | – | Sell |
-3,560
| Closed | -$346K | – | 144 |
|
2023
Q1 | $346K | Sell |
3,560
-997
| -22% | -$96.9K | 0.05% | 123 |
|
2022
Q4 | $472K | Buy |
4,557
+972
| +27% | +$101K | 0.07% | 106 |
|
2022
Q3 | $304K | Buy |
3,585
+468
| +15% | +$39.7K | 0.05% | 123 |
|
2022
Q2 | $258K | Sell |
3,117
-388
| -11% | -$32.1K | 0.05% | 125 |
|
2022
Q1 | $270K | Sell |
3,505
-225
| -6% | -$17.3K | 0.04% | 117 |
|
2021
Q4 | $330K | Sell |
3,730
-279
| -7% | -$24.7K | 0.06% | 103 |
|
2021
Q3 | $310K | Buy |
4,009
+561
| +16% | +$43.4K | 0.04% | 106 |
|
2021
Q2 | $288K | Sell |
3,448
-1,110
| -24% | -$92.7K | 0.03% | 111 |
|
2021
Q1 | $344K | Sell |
4,558
-1,592
| -26% | -$120K | 0.06% | 102 |
|
2020
Q4 | $539K | Buy |
+6,150
| New | +$539K | 0.07% | 97 |
|